ABEO Performance At-A-Glance
Abeona Therapeutics Inc's risk efficiency is -0.69, which is poor. By comparison, the S&P500 is -0.43.
Increasing quickly over the past 4 weeks.
Abeona Therapeutics Inc's dScore is 8.98% , which is more volatile than the S&P500 (2.74%).
Abeona Therapeutics Inc has shrunk by -66.01% over the past year. By comparison, the S&P500 has lost -10.23%.